Skip to Main Content

Author Details

Adrienne M Flanagan
University College London, UCL Cancer Institute
1987
240
72
PMIDPaper TitleJournal TitlePublished Year
37310481Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case.Skeletal Radiol2024
37310481Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case.Skeletal Radiol2024
36598417Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.Cancer Discov2023
36426824Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma.J Pathol2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37593416Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.HGG Adv2023
36706755Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery.Dev Cell2023
37316954Subclassification of epithelioid sarcoma with potential therapeutic impact.J Pathol2023
36932241Diagnostic classification of childhood cancer using multiscale transcriptomics.Nat Med2023
36598417Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.Cancer Discov2023
37596165Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.Cancer Epidemiol2023
37593416Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma.HGG Adv2023
37316954Subclassification of epithelioid sarcoma with potential therapeutic impact.J Pathol2023
36426824Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma.J Pathol2023
36932241Diagnostic classification of childhood cancer using multiscale transcriptomics.Nat Med2023
36706755Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery.Dev Cell2023
34969957Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.Mod Pathol2022
36042521A genetic model for central chondrosarcoma evolution correlates with patient outcome.Genome Med2022
36040039Brown Tumors Belong to the Spectrum of KRAS -driven Neoplasms.Am J Surg Pathol2022
35705804Signatures of copy number alterations in human cancer.Nature2022
36138226Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone.Cell Death Differ2022
35421838Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA.Eur J Cancer2022
36585406Author Correction: Osteosarcoma.Nat Rev Dis Primers2022
34969957Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.Mod Pathol2022
35705804Signatures of copy number alterations in human cancer.Nature2022
35421838Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA.Eur J Cancer2022
36585406Author Correction: Osteosarcoma.Nat Rev Dis Primers2022
36042521A genetic model for central chondrosarcoma evolution correlates with patient outcome.Genome Med2022
36040039Brown Tumors Belong to the Spectrum of KRAS -driven Neoplasms.Am J Surg Pathol2022
36138226Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone.Cell Death Differ2022
32710151EWSR1-SMAD3 fibroblastic tumour of bone: expanding the clinical spectrum.Skeletal Radiol2021
33969640MYC amplifications are common events in childhood osteosarcoma.J Pathol Clin Res2021
34124783AZD8055 enhances in vivo efficacy of afatinib in chordomas.J Pathol2021
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
34282324A pan-cancer landscape of somatic mutations in non-unique regions of the human genome.Nat Biotechnol2021
33949149DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.J Pathol Clin Res2021
32710151EWSR1-SMAD3 fibroblastic tumour of bone: expanding the clinical spectrum.Skeletal Radiol2021
34742484Notochordal Tumors.Surg Pathol Clin2021
34742480Benign Bone-Forming Tumors.Surg Pathol Clin2021
34742484Notochordal Tumors.Surg Pathol Clin2021
34742480Benign Bone-Forming Tumors.Surg Pathol Clin2021
33969640MYC amplifications are common events in childhood osteosarcoma.J Pathol Clin Res2021
34124783AZD8055 enhances in vivo efficacy of afatinib in chordomas.J Pathol2021
33949149DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.J Pathol Clin Res2021
34282324A pan-cancer landscape of somatic mutations in non-unique regions of the human genome.Nat Biotechnol2021
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
32315290HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis.J Clin Invest2020
32252413Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.Genes (Basel)2020
32191290Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.JAMA Oncol2020
  • 1 - 50 of 480

Recommended Authors

Julio A Diaz-Perez
12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 1
Zhongxin Yu
University of Oklahoma Health Sciences Center
Career Start Year 2005
Number of shared co-authors 3
Monica L Calicchio
Boston Children's Hospital
Career Start Year 2004
Number of shared co-authors 2
Robin D LeGallo
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 4
Chantal Pauli
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 2
Nasir Ud Din
Department of Pathology and Laboratory Medicine Aga Khan University Hospital Karachi
Career Start Year 2001
Number of shared co-authors 15
Sung Wook Seo
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 2000
Number of shared co-authors 14
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 30
Andre M Oliveira
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 6
Jaime Ferrer
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 0
Bret Wehrli
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 5
Sara O Vargas
Boston Children's Hospital
Career Start Year 1997
Number of shared co-authors 6
Gonzague de Pinieux
University Hospital of Tours
Career Start Year 1996
Number of shared co-authors 7
Michael T Collins
National Institute of Dental and Craniofacial Research
Career Start Year 1996
Number of shared co-authors 0
Atiya Mansoor
Oregon Health & Science University
Career Start Year 1996
Number of shared co-authors 3
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 26
Jason L Hornick
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 17
Robert L Satcher
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 4
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 7
Scott D Nelson
University of California-Los Angeles
Career Start Year 1990
Number of shared co-authors 2
Luca Sangiorgi
Department of Rare Skeletal Disorders - IRCCS Istituto Ortopedico Rizzoli
Career Start Year 1990
Number of shared co-authors 10
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 25
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 79
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 3
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 11
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year 1981
Number of shared co-authors 31
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 14
David M Parham
Keck School of Medicine, University of Southern California
Career Start Year 1977
Number of shared co-authors 11

Collaborators

Roberto Tirabosco
University College London, UCL Cancer Institute
Co-authored papers 71
Fernanda Amary
Royal National Orthopaedic Hospital
Co-authored papers 56
Michael R Stratton
Wellcome Sanger Institute
Co-authored papers 22
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 20
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 19
Dina Halai
Royal National Orthopaedic Hospital National Health Service Trust
Co-authored papers 18
Patrick S Tarpey
Wellcome Trust Sanger Institute
Co-authored papers 18
Jon Teague
Wellcome Sanger Institute
Co-authored papers 15
Daniel Baumhoer
Co-authored papers 15
Adam Butler
Wellcome Sanger Institute
Co-authored papers 13
Peter Van Loo
The Francis Crick Institute
Co-authored papers 12
Richard Gorlick
University of Texas MD Anderson Cancer Center
Co-authored papers 10
Sandra J Strauss
University College London, Cancer Institute
Co-authored papers 9
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 9
Andrew Menzies
Wellcome Sanger Institute
Co-authored papers 9
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers 9
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 8
Jay S Wunder
University of Toronto
Co-authored papers 8
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 8
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 8
Claudia Maria Hattinger
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 7
Irene L Andrulis
University of Toronto
Co-authored papers 7
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 7
Manasa Ramakrishna
Co-authored papers 7
Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
Co-authored papers 7
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 7
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 7
Sunil R Lakhani
University of Queensland
Co-authored papers 7
Lisa Mirabello
National Cancer Institute
Co-authored papers 7
Massimo Serra
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 7
Release 1.2